Boehringer Ingelheim India Partners with EMRI Green Health Services Transforming Pre-Hospital Stroke Care in India
Stroke remains one of the leading causes of death and disability in India, affecting nearly two million people annually. Despite […]
Boehringer Ingelheim India and Lupin signs co-marketing agreement
Boehringer Ingelheim and pharma major Lupin Limited (Lupin) has entered into strategic alliance to co-market Empagliflozin, a novel sodium glucose […]
